Class of Stock [Axis] Class of Stock [Domain] Statement of Financial Position [Abstract] Current Assets: Assets, Current [Abstract] Cash and Cash Equivalents Cash and cash equivalents Cash and Cash Equivalent Accounts Receivable Accounts Receivable, after Allowance for Credit Loss, Current Prepaid and Other Assets Prepaid Expense and Other Assets, Current Short-Term Investments Short-Term Investments Inventory Inventory (Note 3) Inventory, Net Total Current Assets Assets, Current Other Assets: Other Assets [Abstract] Long-Term Prepaid Expense Long-term prepaid expense Prepaid Expense, Noncurrent Intangible Assets, net Intangible Assets, net (Note 5) Intangible Assets, Net (Excluding Goodwill) Total Other Assets Other Assets, Noncurrent Total Assets Assets Current Liabilities: Liabilities, Current [Abstract] Total Current Liabilities Liabilities, Current Long-Term Liabilities: Liabilities, Noncurrent [Abstract] Total Long-Term Liabilities Long-Term Liabilities Liabilities, Noncurrent Total Liabilities Liabilities Accumulated Other Comprehensive Income Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated Deficit Retained Earnings (Accumulated Deficit) 60P Shareholders’ Equity: Equity, Attributable to Parent Noncontrolling Interest Equity, Attributable to Noncontrolling Interest Statement [Table] Series A Preferred Stock Series A Series A Preferred Stock [Member] Series A Preferred Stock [Member] Statement [Line Items] Preferred stock, shares authorized Preferred stock shares authorized Preferred Stock, Shares Authorized Preferred stock, shares issued Preferred stock shares issued Preferred Stock, Shares Issued Preferred stock, shares outstanding Preferred stock shares outstanding Preferred Stock, Shares Outstanding Common stock, shares authorized Common stock shares authorized Common Stock, Shares Authorized Common stock, shares issued Common Stock, Shares, Issued Common stock, shares outstanding Common stock outstanding Common Stock, Shares, Outstanding Income Statement [Abstract] Cost of Revenues Cost of Revenue Research Revenues Revenue Not from Contract with Customer, Other Operating Expenses: Operating Expenses [Abstract] Research and Development Research and development (in Dollars) Research and Development Expense General and Administrative Expenses General and Administrative Expense Total Operating Expenses Operating Expenses Loss from Operations Operating Income (Loss) Interest Expense Interest Expense, Nonoperating Change in Fair Value of Derivative Liabilities Fair Value Adjustment of Warrants Other Income, net Other Nonoperating Income (Expense) Net Loss – Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Cumulative Dividends on Series A Preferred Stock Preferred Stock Dividends and Other Adjustments Basic (in Dollars per share) Earnings Per Share, Basic Diluted (in Dollars per share) Earnings Per Share, Diluted Basic (in Shares) Weighted Average Number of Shares Outstanding, Basic Diluted (in Shares) Weighted Average Number of Shares Outstanding, Diluted Statement of Stockholders' Equity [Abstract] Equity Components [Axis] Preferred Stock Preferred Stock [Member] Additional Paid-In Capital Additional Paid-in Capital [Member] Accumulated Deficit Retained Earnings, Unappropriated [Member] Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Total Shareholders’ Equity Attributable to 60P Total Shareholders’ Equity (Deficit) Attributable to 60P Parent [Member] Noncontrolling Interest on Shareholders Noncontrolling Interest [Member] Equity Component [Domain] Balance (in Shares) Balance (in Shares) Shares, Outstanding Issuance of common stock and warrants pursuant to January 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6) The amount of issuance of common stock and warrants pursuant to January 2025 Offering, net of offering costs ... Stock Issued During Period Value Issuance Of Common Stock And Warrants Pursuant To January2025 Offering Net Of Offering Costs Issuance of common stock and warrants pursuant to January 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6) (in Shares) Issuance of common stock and warrants pursuant to January 2025 Offering, net of offering costs . Stock Issued During Period Issuance Of Common Stock And Warrants Pursuant To January2025 Offering Net Of Offering Costs Issuance of common stock and warrants pursuant to February 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6) The amount of Issuance of common stock and warrants pursuant to February 2025 Offering, net of offering costs ... Stock Issued During Period Value Issuance Of Common Stock And Warrants Pursuant To February2025 Offering Net Of Offering Costs Issuance of common stock and warrants pursuant to February 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6) (in Shares) Issuance of common stock and warrants pursuant to February 2025 Offering, net of offering costs . Stock Issued During Period Issuance Of Common Stock And Warrants Pursuant To February2025 Offering Net Of Offering Costs Issuance of common stock upon exercise of Pre-Funded Warrants Issuance of common stock upon exercise of pre-funded warrants. Stock Issued During Period Value Stock Issuance Of Common Stock Upon Exercise Of Pre Funded Warrants Issuance of shares for annual performance bonuses, net of shares withheld for taxes Shares of common stock to the executives in settlement The amount of issuance of shares for annual performance bonuses, net of shares withheld for taxes. Stock Issued During Period Value Issuance Of Shares For Annual Performance Bonuses Net Of Shares Withheld For Taxes Share-based compensation expense Stock option award APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Depreciation Depreciation Amortization Amortization Amortization of Capitalized Share-Based Payments Amount of amortization of capitalized share-based payments. Amortization Of Capitalized Share Based Payments Share-Based Compensation under Equity Incentive Plan Employee Benefits and Share-Based Compensation Changes in Operating Assets and Liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Accounts Receivable Increase (Decrease) in Accounts Receivable Prepaid and Other Assets Increase (Decrease) in Prepaid Expense and Other Assets Inventory Increase (Decrease) in Inventories Accounts Payable and Accrued Liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Accrued Interest, net Increase (Decrease) in Accrued Interest Receivable, Net Net Cash Used in Operating Activities Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation CASH FLOWS FROM INVESTING ACTIVITIES Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Capitalization of Patents The cash outflow to acquire an asset without physical form usually arising from contractual or other legal rights, excluding goodwill. Payment Of Capitalization Of Patents Purchases of Fixed Assets Payments to Acquire Property, Plant, and Equipment Acquisition of Intangibles Payments to Acquire Intangible Assets Maturities of Short-Term Investments Proceeds from Maturities, Prepayments and Calls of Short-Term Investments CASH FLOWS FROM FINANCING ACTIVITIES Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Net Proceeds from January 2025 Offering The amount of net proceeds from january 2025 offering. Net Proceeds From January2025 Offering Net Proceeds from February 2025 Offering The amount of net proceeds from february 2025 offering. Net Proceeds From February2025 Offering Shares Withheld for Net Share Settlement of Performance Bonuses Payment, Tax Withholding, Share-Based Payment Arrangement Proceeds from Exercise of Pre-Funded Warrants Proceeds from exercise of pre-funded warrants. Proceeds From Exercise Of Pre Funded Warrants Net Cash Provided by Financing Activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Effect of Exchange Rate Changes on Cash Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Change in Cash and Cash Equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash and Cash Equivalents—Beginning of Period Cash and Cash Equivalents—End of Period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation NONCASH INVESTING/FINANCING ACTIVITIES Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Purchases of Fixed Assets included in Accounts Payable Noncash or Part Noncash Acquisition, Fixed Assets Acquired Gross Shares Issued for Annual Performance Bonuses Represent the amount of gross shares issued for annual performance bonuses. Gross Shares Issued For Annual Performance Bonuses NATURE OF OPERATIONS Nature of Operations [Text Block] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] INVENTORY Inventory Disclosure [Text Block] PROPERTY AND EQUIPMENT Property, Plant and Equipment Disclosure [Text Block] INTANGIBLE ASSETS Intangible Assets Disclosure [Text Block] DEBT Debt Disclosure [Text Block] DERIVATIVE LIABILITIES Derivative Instruments and Hedging Activities Disclosure [Text Block] INCOME TAXES Income Tax Disclosure [Text Block] SHARE-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] SUBSEQUENT EVENTS Subsequent Events [Text Block] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Reverse Stock Splits Stockholders' Equity, Policy [Policy Text Block] Concentrations Concentration Risk, Credit Risk, Policy [Policy Text Block] Segment Information Segment Reporting, Policy [Policy Text Block] Derivative Liabilities Derivatives, Policy [Policy Text Block] Equity-Classified Warrants Disclosure of accounting policy for equity-classified warrants. Equity Classified Warrants Policy Text Block Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Assets and Liabilities Not Measured at Fair Value on a Recurring Basis Disclosure of accounting policy for assets and liabilities not measured at fair value on a recurring basis. Assets And Liabilities Not Measured At Fair Value On ARecurring Basis Policy Text Block Foreign Currency Transactions and Translation Foreign Currency Transactions and Translations Policy [Policy Text Block] Reclassifications Reclassification, Comparability Adjustment [Policy Text Block] Share-Based Payments Share-Based Payment Arrangement [Policy Text Block] Related Parties Compensation Related Costs, Policy [Policy Text Block] Subsequent Events Subsequent Events, Policy [Policy Text Block] Recently Adopted and Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Schedule of Liabilities Measured at Fair Value Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Exchange Rates along with Historical Rates Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block] Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Schedule of Property and Equipment Property, Plant and Equipment [Table Text Block] Schedule of Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of Estimated Future Amortization Expense for Our Patents and Website Development Costs Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Schedule of Equity-Classified Warrants Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of the Current Future Payment Obligations Schedule of Maturities of Long-Term Debt [Table Text Block] Schedule of Derivative Liabilities Measured at Fair Value on a Recurring Basis Schedule of Derivative Liabilities at Fair Value [Table Text Block] Schedule of Share-Based Compensation Expenses Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of Fair Value of Options Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block] Nature of Operations (Details) [Table] Sale of Stock [Axis] Sale of Stock [Domain] Initial Public Offering [Member] IPO [Member] IPO [Member] Tradeable Warrants [Member] Tradeable Warrants Member Non-Tradeable Warrants [Member] Nontradeable Warrants Member Tradeable and Non-Tradeable Warrants [Member] Tradeable And Non Tradeable Warrants Member Nature of Operations [Line Items] Number of shares issued (in Shares) Stock Issued During Period, Shares, New Issues Price per unit (in Dollars per share) Shares Issued, Price Per Share Net proceeds Proceeds from Issuance Initial Public Offering Summary of Significant Accounting Policies (Details) [Table] Reverse Stock Splits [Member] Reverse Stock Splits Member Net Loss Per Common Share [Member] Net Loss Per Common Share Member Concentration Risk Type [Axis] Concentration Risk Type [Domain] Customer Concentration Risk [Member] Customer Concentration Risk [Member] Customer [Axis] Customer [Domain] Customer One [Member] Significant Customers [Member] Significant Customers Member Customer Two [Member] Customer Two Member Customer Three [Member] Customer Three Member Significant Customer One [Member] Significant Customer One Member Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Accounts Receivable [Member] Accounts Receivable [Member] Revenue Benchmark [Member] Revenue Benchmark [Member] Summary of Significant Accounting Policies [Line Items] Reverse stock split Stockholders' Equity, Reverse Stock Split Concentration percentage Concentration Risk, Percentage Cash equivalents and short-term (in Dollars) Cash, Cash Equivalents, and Short-Term Investments Schedule Of Liabilities Measured At Fair Value Abstract Summary of Significant Accounting Policies - Schedule of Liabilities Measured at Fair Value (Details) [Table] Financial Instrument [Axis] Financial Instruments [Domain] Derivative Liabilities [Member] Derivative [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Level 2 [Member] Fair Value, Inputs, Level 2 [Member] Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Schedule of Liabilities Measured at Fair Value [Line Items] Schedule Of Exchange Rates Along With Historical Rates Abstract Summary of Significant Accounting Policies - Schedule of Exchange Rates along with Historical Rates (Details) [Table] Currency [Axis] United States of America, Dollars United States of America, Dollars Schedule of Exchange Rates along with Historical Rates [Line Items] Average Exchange Rate Average Exchange Rate. Average Exchange Rate Exchange Rate Foreign Currency Exchange Rate, Translation All Currencies [Domain] Schedule of Inventory [Abstract] Raw Material (API) Inventory, Raw Materials, Gross Work in Process Inventory, Work in Process, Gross Finished Goods Inventory, Finished Goods, Gross Depreciation Depreciation, Depletion and Amortization Schedule Of Property And Equipment Abstract Property, Plant and Equipment [Table] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Domain] Lab Equipment [Member] Lab Equipment Member Machinery [Member] Machinery and Equipment [Member] Computer Equipment [Member] Computer Equipment [Member] Furniture [Member] Furniture and Fixtures [Member] Schedule of Property and Equipment [Line Items] Property and Equipment, at cost Property, Plant and Equipment, Gross Accumulated Depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Capitalized website development-related costs Amount of capitalized website development-related costs. Capitalized Website Developmentrelated Costs Amortization expense Amortization of Intangible Assets Write-downs Impairment of Intangible Assets (Excluding Goodwill) Capitalized patent expenses Amount of capitalized patent expenses. Capitalized Patent Expenses Schedule of Intangible Assets [Abstract] Patents Finite-Lived Patents, Gross Website Development Costs Gross carrying amount before accumulated amortization as of the balance sheet date of the costs. Finite Lived Website Development Costs Gross Intangible Assets, at cost Finite-Lived Intangible Assets, Gross Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Schedule Of Estimated Future Amortization Expense For Our Patents And Website Development Costs Abstract Intangible Assets - Schedule of Estimated Future Amortization Expense for Our Patents and Website Development Costs (Details) [Table] Finite-Lived Intangible Assets by Major Class [Axis] Patents [Member] Patents [Member] Website Development Costs [Member] Software and Software Development Costs [Member] Schedule of Estimated Future Amortization Expense for Our Patents and Website Development Costs [Line Items] Thereafter Finite-Lived Intangible Asset, Expected Amortization, after Year Five Total Finite-Lived Intangible Assets, Net Finite-Lived Intangible Assets, Major Class Name [Domain] Stockholders' Equity (Details) [Table] Over-Allotment Option [Member] Over-Allotment Option [Member] Series A Non-Voting Convertible Preferred Stock [Member] Series ANon Voting Convertible Preferred Stock Member Related Party Transaction [Axis] Related Party Transaction [Domain] WallachBeth Capital LLC [Member] Wallach Beth Capital LLCMember Related and Nonrelated Parties [Axis] Related and Nonrelated Parties [Domain] Award Date [Axis] Award Date [Domain] January 2024 Offering [Member] January2024 Offering Member Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Placement Agent Warrants [Member] Placement Agent Warrants Member Pre-Funded Warrant [Member] Pre Funded Warrant Member January 2024 Pre-Funded Warrants [Member] January Two Thousand Twenty Four Pre Funded Warrants Member January 2024 Warrants [Member] January Two Thousand Twenty Four Warrant Member January 2024 Representative Warrants [Member] January Representative Warrants Member Stockholders’ Equity [Line Items] Designated shares Designated shares (in Shares) Excess Stock, Shares Authorized Additional common share Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Aggregate shares of common stock Sale of Stock, Number of Shares Issued in Transaction Units issued Number of units issued during the period. Units Issued During Period Shares New Issues Warrant shares Class of Warrant or Right, Outstanding Shares warrants Number of shares warrants. Shares Of Warrants Number of warrant exercisable Number of warrants exercisable. Numberof Warrant Exercisable Number of shares Number of shares purchased or issued. Number Of Shares Cash proceeds (in Dollars) Proceeds from Divestiture of Businesses, Net of Cash Divested Dividends percentage Preferred Stock, Dividend Rate, Percentage Schedule Of Equity Classified Warrants Abstract Class of Warrant or Right [Table] Schedule of Equity-Classified Warrants [Line Items] Number of Warrants, Total outstanding, Beginning Number of Warrants, Total outstanding, Ending Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Weighted Average Exercise Price, Total outstanding, Beginning Weighted Average Exercise Price, Total outstanding, Ending Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted Average Remaining Contractual Life (Years), Total outstanding, Beginning Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Weighted Average Remaining Contractual Life (Years), Granted Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Remaining Contractual Life Years Granted Number of Warrants, Exercised The number of number of warrants, exercised. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Number Of Warrants Exercised Weighted Average Remaining Contractual Life (Years), Exercised Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Remaining Contractual Life Years Exercised Number of Warrants, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Weighted Average Exercise Price, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Weighted Average Remaining Contractual Life (Years), Forfeited Weighted average remaining contractual life (years), forfeited. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Remaining Contractual Life Years Forfeited Number of Warrants, Expired Number of number of warrants, expired. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Number Of Warrants Expired Weighted Average Exercise Price, Expired Weighted average exercise price, expired. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Exercise Price Expired Weighted Average Remaining Contractual Life (Years), Expired Weighted average remaining contractual life (years), expired. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Remaining Contractual Life Years Expired Weighted Average Remaining Contractual Life (Years), Total outstanding, Ending Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms1 Weighted Average Remaining Contractual Life (Years),Total exercisable Weighted average remaining contractual term exercisable for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Outstanding Weighted Average Remaining Contractual Terms Debt (Details) [Table] Debt Instrument [Axis] Debt Instrument, Name [Domain] Small Business Administration [Member] Small Business Administration Member Balloon Payment [Member] Balloon Payment Member SBA [Member] SBAMember Debt [Line Items] Principal amount Debt Instrument, Face Amount Annual interest rate Debt Instrument, Interest Rate, Effective Percentage Balloon payment Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid Maturity date Debt Instrument, Maturity Date Amortization discount Amortization of Debt Issuance Costs and Discounts Current maturity Long-Term Debt, Current Maturities Schedule of the Current Future Payment Obligations [Abstract] Thereafter Long-Term Debt, Maturity, after Year Five Total Long-Term Debt Derivative Liabilities (Details) [Table] Derivative Liabilities [Line Items] Milestone Payment The amount of milestone payment. Milestone Payment Redemption term. Preferred Stock, Redemption Terms Royalty percentage The percentage of royalty. Royalty Percentage Schedule Of Derivative Liabilities Measured At Fair Value On ARecurring Basis Abstract Derivative Liabilities - Schedule of Derivative Liabilities Measured at Fair Value on a Recurring Basis (Details) [Table] Measurement Frequency [Axis] Fair Value, Recurring [Member] Fair Value, Recurring [Member] Derivative Instrument [Axis] Derivative Contract [Domain] Contingent Milestone Payment [Member] Contingent Milestone Payment [Member] Contingent Milestone Payment Member Bridge Shares [Member] Bridge Shares Member Schedule of Derivative Liabilities Measured at Fair Value on a Recurring Basis [Line Items] Change in fair value Fair value, measurement with unobservable inputs reconciliation, recurring Basis, fair value - mark to market adjustment. Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Mark To Market Adjustment Measurement Frequency [Domain] U.S. federal net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards, Domestic U.S. federal tax Deferred Tax Assets, Tax Credit Carryforwards, Other Share-Based Compensation (Details) [Table] Plan Name [Axis] Plan Name [Domain] Two Thousand Twenty Two Equity Incentive Plan [Member] Two Thousand Twenty Two Equity Incentive Plan Member Vesting [Axis] Vesting [Domain] First Tranche [Member] Share-Based Payment Arrangement, Tranche One [Member] Award Type [Domain] Stock Options [Member] Stock Options Member Restricted Stock Units (RSUs) [Member] Restricted Stock Units (RSUs) [Member] Schedule of Share-Based Compensation Expenses [Line Items] Share-Based Compensation [Line Items] Options Vesting percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Weighted average grant date fair value of options granted (in Dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value Total Share-Based Compensation Expense Included in Operating Expenses Compensation expense Share-Based Payment Arrangement, Expense Cash Cash Shares payroll tax withholdings (in Shares) The shares issued payroll taxes withholdings. Shares Issued Payroll Taxes Withholdings Unamortized balance The amount of unamortized balance. Unamortized Balance Schedule Of Share Based Compensation Expenses Abstract Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Domain] General and Administrative Expenses [Member] General and Administrative Expense [Member] Fair Value Measurement Inputs and Valuation Techniques [Abstract] Weighted-average grant date fair value (in Dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Commitments and Contingencies (Details) [Table] Statistical Measurement [Axis] Statistical Measurement [Domain] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Title and Position [Axis] Title and Position [Domain] Board of Directors [Member] Board of Directors Chairman [Member] Board of Directors Chairman [Member] Cheryl Xu [Member] Cheryl Xu Member Paul Field [Member] Paul Field Member Charles Allen [Member] Charles Allen Member Stephen Toovey [Member] Stephen Toovey Member US Government Sales [Member] USGovernment Sales Member U.S. Army Agreement [Member] USArmy Agreement Member Commitments and Contingencies [Line Items] Operating lease costs Operating Lease, Cost Cash compensation Compensation and Benefits Trust Number of non audit committee chairs Number of non-audit committee chairs. Number Of Non Audit Committee Chairs Payment Business Combination, Contingent Consideration, Liability Licensed technology term. Licensed technology term. Licensed Technology Term Annual royalty payment Percentage of annual royalty payment. Annual Royalty Payment Percentage Royalty expense Royalty Expense Percentage of royalty payments of net sales Percentage of royalty payments of net sales. Percentage Of Royalty Payments Of Net Sales Percentage of treatment of babesiosis Percentage of treatment of babesiosis. Percentage Of Treatment Of Babesiosis Percentage of revenue Revenue, Remaining Performance Obligation, Percentage Research and Development Expense [Member] Cover [Abstract] Document Information [Line Items] Document Type Amendment Flag Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Filer Category Entity Emerging Growth Company Entity Small Business Entity File Number Entity Tax Identification Number Entity Interactive Data Current Entity Shell Company Document Quarterly Report Document Transition Report Entity Ex Transition Period Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Security Exchange Name Trading Symbol Entity Common Stock, Shares Outstanding Entity Current Reporting Status Warrants [Member] Warrants, each warrant to purchase one share of Common Stock Warrant [Member] Award Type Axis Entities [Table] Loss from Operations before Provision for Income Taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Net Loss – attributed to 60 Degrees Pharmaceuticals, Inc. Net Income (Loss) Comprehensive Loss: Other Comprehensive Income (Loss), Net of Tax [Abstract] Total Comprehensive Loss Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive Loss – attributed to 60 Degrees Pharmaceuticals, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent Net Loss - attributed to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Net Loss per Common Share: Earnings Per Share [Abstract] Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Noncash Item [Abstract] Lessee, Operating Lease, Renewal Term Office space lease renewed term Stock option granted to number of executives Number of executives. Number Of Executives Significant Customer Two [Member] This member stands for the information pertaining to "Significant Customer Two". Significant Customer Two [Member] Significant Customer Three [Member] Significant Customer Three [Member] This member stands for the information pertaining to "Significant Customer Three". Trevally, LLC [Member] Trevally, LLC [Member] This member stands for the information pertaining to "Trevally, LLC". Agreed to return shares Agreed to return shares Number of agreed to return shares. Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Stock option granted Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] July Two Thousand Twenty Five Pre Funded Warrants [Member] This member stands for the information pertaining to "July 2025 Pre-Funded Warrants". July 2025 Pre-Funded Warrants [Member] July Two Thousand Twenty Five A One Warrants [Member] This member stands for the information pertaining to "July 2025 A-1 Warrants". July 2025 A-1 Warrants [Member] July Two Thousand Twenty Five A Two Warrants [Member] This member stands for the information pertaining to "July 2025 A-2 Warrants". July 2025 A-2 Warrants [Member] July Two Thousand Twenty Five Placement Agent Warrants [Member] This member stands for the information pertaining to "July 2025 Placement Agent Warrants". July 2025 Placement Agent Warrants [Member] Subsequent Event [Line Items] Class of Warrant or Right, Date from which Warrants or Rights Exercisable Date from which warrants exercisable Warrants and Rights Outstanding, Maturity Date Date of warrants exercisable expiry Representative warrants exercisable term Warrants and Rights Outstanding, Term Warrants exercisable expiry term July 2025 Offering [Member] July 2025 Offering [Member] This member stands for the information pertaining to "July 2025 Offering". Net Loss per Common Share Earnings Per Share, Policy [Policy Text Block] Product Revenues – net of Discounts and Rebates Revenues SHAREHOLDERS' EQUITY: Equity, Attributable to Parent [Abstract] Total Shareholders' Equity Balance Balance Equity, Including Portion Attributable to Noncontrolling Interest Total Liabilities and Shareholders' Equity Liabilities and Equity Net foreign translation gain (loss) Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Net Loss – Noncontrolling Interest Net Income (Loss) Attributable to Noncontrolling Interest Inventory Write-down Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Option granted to purchase common stock period Assets [Abstract] ASSETS: Insider Trading Arrangements [Line Items] Rule 10b5-1 Arrangement Adopted [Flag] Non-Rule 10b5-1 Arrangement Adopted [Flag] Rule 10b5-1 Arrangement Terminated [Flag] Non-Rule 10b5-1 Arrangement Terminated [Flag] NATURE OF OPERATIONS SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES INVENTORY PROPERTY AND EQUIPMENT INTANGIBLE ASSETS DEBT DERIVATIVE LIABILITIES INCOME TAXES SHARE-BASED COMPENSATION COMMITMENTS AND CONTINGENCIES SUBSEQUENT EVENTS Federal, District of Columbia Income Tax Provision or Benefit Federal, State, and Local, Income Tax Expense (Benefit), Continuing Operations Purchase of common stock Stock Issued During Period, Shares, Other Voluntary conversion of Series A Preferred Stock into common stock (in Shares) Proceeds from Warrant Exercises Issuance of shares for annual performance bonuses, net of shares withheld for taxes (in Shares) Issuance of shares for annual performance bonuses, net of shares withheld for taxes (in Shares). Stock Issued During Period Issuance Of Shares For Annual Performance Bonuses Net Of Shares Withheld For Taxesin Shares Shares of common stock to the executives in settlement ATM Offering Net of Offering Costs Paid ATM Offering, net of offering costs paid ATM Offering, net of offering costs paid. Inventory, Gross Total Inventory Series A Warrants [Member] Series A Warrants [Member] This member stands for the information pertaining to "Series A Warrants". Series B Warrants [Member] Series B Warrants [Member] This member stands for the information pertaining to "Series B Warrants". Convertible Preferred Stock, Shares Issued upon Conversion Converted shares Conversion of Stock, Shares Converted (in Shares) Conversion of Stock, Shares Converted Shares converted Warrant, Exercise Price, Decrease Exercise price (in Dollars per share) Warrants and Rights Outstanding Warrants and rights outstanding Preferred Stock, Convertible, Shares Issuable Preferred stock, convertible, shares issuable Convertible Common Stock [Member] H C Wainwright And Co LLC [Member] H.C. Wainwright & Co., LLC [Member] This member stands for the information pertaining to "H.C. Wainwright & Co., LLC ". September Two Thousand Twenty Four Agent Warrants [Member] September 2024 Agent Warrants [Member] This member stands for the information pertaining to "September 2024 Agent Warrants". Series A And Series B Warrants [Member] Series A And Series B Warrants [Member] This member stands for the information pertaining to "Series B And Series B Warrants". ATM Offering Shares ATM Offering ATM Offering. Property and Equipment, net Property and Equipment, net (Note 4) Property, Plant and Equipment, Net Sale of stock, percentage of ownership Sale of Stock, Percentage of Ownership after Transaction Tufts Medical Center Agreement [Member] Tufts MC Agreement [Member] This member stands for the information pertaining to "Tufts MC Agreement". Director [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Terms of Award Stock option granted term Equity-based compensation awards term Loss Contingency, Pending Claims, Number Number of pending or threatened lawsuits Share-based Compensation Arrangement By Share-based Payment Award Fair Value Assumptions Expected Term 1 Minimum Expected term, minimum (years) Expected minimum term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Share-based Compensation Arrangement By Share-based Payment Award Fair Value Assumptions Expected Term 1 Maximum Expected term, maximum (years) Expected maximum term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Risk-free interest rate, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Risk-free interest rate, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Expected volatility, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Expected volatility, maximum 2025 ATM Agreement [Member] At-the-Market 2025 Agreement [Member] This member stands for the information pertaining to "2025 ATM Agreement". Sales agent commission percentage Sales Agent Commission Percentage Percentage of sales agent commission. Number of Directors Number of directors. Number of directors Number of director nominees Per share exercise price (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Number of shares available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Number of shares available for issuance (in shares) Noncash or Part Noncash Acquisition, Intangible Assets Acquired Capitalized Patent Costs included in Accounts Payable Common stock, par value (in dollars per share) Common stock par value (in dollars per share) Common Stock, Par or Stated Value Per Share Preferred stock, par value (in dollars per share) Preferred stock shares, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Sale of stock price per share (in dollars per share) Sale of Stock, Price Per Share Sale of stock price per unit (in dollars per unit) Exercise price per share (in dollars per share) Exercise price of warrants (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Deducting placement agent fees Proceeds from Issuance of Private Placement Net proceeds from Private Placement Net Proceeds from offering Net proceeds Proceeds from Debt, Net of Issuance Costs Other offering expenses paid Cash outflow for other offering expenses. Other Offering Expenses Paid Exercise price (in dollars per share) Warrant, Exercise Price, Increase Cash proceeds Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Dividends preferred stock Dividends, Preferred Stock Common stock conversion price per share (in dollars per share) Common Stock, Convertible, Conversion Price, Increase Common Stock Aggregate Offering Price Common stock aggregate offering price Common stock having an aggregate offering price. Proceeds from Other Equity Gross proceeds Weighted Average Exercise Price,Total exercisable Weighted average fair value as of the exercisable date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Grant Date Fair Value Number of Warrants, Total exercisable The number of equity-based payment instruments, excluding stock (or unit) options, that were exercisable, during the reporting period. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Number of warrants exercisable Issuance of common stock upon exercise of Pre-Funded Warrants (in shares) Issuance of common stock upon exercise of Pre-Funded Warrants (in Shares). Stock Issued During Period Issuance Of Common Stock Upon Exercise Of Pre Funded Warrantsin Shares Weighted Average Exercise Price, Exercised Weighted average exercise price, exercised. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Exercise Price Exercised Weighted average exercise price (in dollars per share) Common stock aggregate gross sales proceeds authorized Common Stock Aggregate Gross Sales Proceed Authorized Authorized aggregate gross sales proceeds of common stock. Proceeds From Common Stock Sales Agreement Net The cash inflow associated with common stock sales agreement. Proceeds from common stock sales agreement net Accounts Receivable Or Revenue Benchmark [Member] Accounts Receivable Or Sales Revenue Net [Member] This member stands for the information pertaining to "Accounts Receivable Or Revenue Benchmark LIABILITIES AND SHAREHOLDERS' EQUITY: Liabilities and Equity [Abstract] Issuance of common stock pursuant to ATM Offering, net of offering costs paid at closing and deferred offering costs (Note 6) Issuance of common stock pursuant to ATM offering. Stock Issued During Period Value Issuance Of Common Stock Pursuant To ATMOffering Net Of Offering Costs Issuance of common stock pursuant to ATM Offering, net of offering costs paid at closing and deferred offering costs (Note 6) (in Shares) Issuance Of Common Stock Pursuant To ATMOffering Net Of Offering Costs Paid Issuance of common stock pursuant to ATM offering. Sales agreement termination date Sales Agreement Termination Date Termination date of sales agreement. 2027 Finite-Lived Intangible Asset, Expected Amortization, Year One 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Two 2029 Finite-Lived Intangible Asset, Expected Amortization, Year Three 2030 Finite-Lived Intangible Asset, Expected Amortization, Year Four 2027 Long-Term Debt, Maturity, Year One 2028 Long-Term Debt, Maturity, Year Two 2029 Long-Term Debt, Maturity, Year Three 2030 Long-Term Debt, Maturity, Year Four Additional Paid-in Capital Additional Paid in Capital Gross Profit Gross Profit Net Revenue The amount of net revenue loss. Net Revenue Loss Share rounding adjustment for reverse stock split Value of issuance of common stock for fractional shares pursuant to Reverse Stock split rounding adjustment. Stock Issued During Period Value Issuance Of Common Stock For Fractional Shares Pursuant To Reverse Stock Split Rounding Adjustment Stock Issued During Period, Shares, Reverse Stock Splits Share rounding adjustment for reverse stock split (in shares) Proceeds from Issuance A T M Offering Costs Net Proceeds from ATM Offering Proceeds from ATM offering, net of offering cost. Valuation Of Contingent Milestone Payment Discount Rate Valuation of contingent milestone payment, discount rate Discount rate for valuation of contingent milestone payment. Unamortized Balance Prepaid Assets Unamortized balance of prepaid assets Unamortized Balance Prepaid Assets. Unamortized Balance Of Prepaid Assets Recognized Ratably Over Remaining Service Period Unamortized balance of prepaid assets recognized ratably over remaining service period Amount of unamortized balance of prepaid assets recognized ratably over remaining service period. Unamortized Balance Of Prepaid Assets Remaining Balance Recognized As Research And Development Services Unamortized balance of prepaid assets remaining balance recognized as research and development services Amount of Unamortized balance of prepaid assets remaining balance recognized as research and development services. Lessee, Operating Lease, Liability, to be Paid, Year One Short-term lease Number of Tranches Number of tranches Number of tranches. At The Market 2026 Offering [Member] 2026 ATM Offering [Member] This member stands for the information pertaining to "2026 ATM Offering". Increased Common Stock Aggregate Gross Sales Proceed Authorized Increased common stock aggregate gross sales proceeds authorized Authorized increased aggregate gross sales proceeds of common stock. Reverse Stock Split Fractional Shares Rounding Adjustment Share rounding adjustment for Reverse Stock Split (in Shares) Share rounding adjustment for Reverse Stock Split. Supplier [Axis] Supplier [Domain] This member stands for the information pertaining to "Consulting Areement ". Consulting Agreement [Member] Consulting Agreement [Member] Number of Warrants, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Number of warrants granted Restricted stock unit granted Weighted Average Exercise Price, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Restricted stock unit grant date fair value Description of consulting agreement term Description of consulting agreement term. Description Consulting Agreement Term Additional restricted stock unit granted each month The number of additional unit grants made each month on other than stock (or unit) option plans.  Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Additional Grants Each Month Write-offs of Capitalized Patents The amount of write-offs of capitalized patents. Writeoffs Of Capitalized Patents Write-down for obsolete patents January 2025 Offering [Member] This member stands for information pertaining to "January 2025 Offering". January 2025 Offering [Member] Class of Warrant or Rights Expiry Term Expiry term of class of warrant or rights. Warrant expiry period January Two Thousand Twenty Five Agent Warrant [Member] This member stands for information pertaining to "January 2025 Agent Warrants". January 2025 Agent Warrants [Member] January Two Thousand Twenty Five Warrant [Member] This member stands for information pertaining to "January 2025 Warrants". January 2025 Warrants [Member] February 2025 Offering [Member] This member stands for information pertaining to "February 2025 Offering". February 2025 Offering [Member] February Two Thousand Twenty Five Warrant [Member] This member stands for information pertaining to "February 2025 Warrants". February 2025 Warrants [Member] February Two Thousand Twenty Five Agent Warrant [Member] This member stands for information pertaining to "February 2025 Agent Warrants". February 2025 Agent Warrants [Member] Net Loss including Noncontrolling Interest Net Loss Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Weighted Average Number of Common Shares Outstanding Weighted Average Number of Shares Outstanding, Basic [Abstract] Net Cash Provided by Investing Activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Inventory, LIFO Reserve, Period Charge Change in Inventory Reserve Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend Expected dividend yield March 2026 At-the-Market Agreement [Member] This member stands for information pertaining to "March 2026 At-the-Market Agreement". Common stock aggregate gross sales proceeds authorized increase Authorized aggregate gross sales proceeds of common stock increase. Preferred Stock, Convertible, Conversion Price Preferred stock converted shares (in Dollars per share) Knight Therapeutics Inc [Member] Knight Therapeutics, Inc. [Member] Payments of Stock Issuance Costs Settlement of accrued offering costs Noncash or Part Noncash Acquisition, Other Assets Acquired Capitalized Software Costs included in Accounts Payable 2026 (remaining six months) Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Inventory Reversal Inventory reversal Amount of inventory reversal. Inventory Adjustments Reserve for Expiring Inventory Reserve for Expiring Inventory July 2026 Offering [Member] July 2026 Offering [Member] This member stands for the information pertaining to "July 2026 Offering". Stock Issued During Period Issuance Of Common Stock And Warrants Pursuant To July 2026 Offering Net Of Offering Costs Issuance of common stock and warrants pursuant to July 2026 offering, net of offering costs paid at closing and deferred offering costs Issuance of common stock and warrants pursuant to July 2026 offering, net of offering costs. Gross Proceeds From July 2026 Offering Gross Proceeds from July 2026 Offering The amount of gross proceeds from july 2026 offering. Net Proceeds From July 2026 Offering Net Proceeds from July 2026 Offering The amount of net proceeds from july 2026 offering. Exercise of warrants Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrant sale Total Interest and Other Income (Loss), net Interest Income (Expense), Nonoperating Unrealized Foreign Currency Translation Gain Unrealized Gain (Loss), Foreign Currency Transaction, after Tax Change in Fair Value of Derivative Liabilities (Loss) on change in fair value of derivative liabilities Derivative, Gain (Loss) on Derivative, Net Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Settlement of accrued offering costs from ATM offering Piramal [Member] This member stands for information pertaining to "Piramal". Piramal [Member] Purchase Obligation Purchase obligation Purchase Obligation, to be Paid, Remainder of Fiscal Year Purchase obligation, around december 2026 Purchase Obligation, to be Paid, Year One Purchase obligation, march 2027 2026 (remaining six months) Long-Term Debt, Maturity, Remainder of Fiscal Year Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Accrued Clinical Trial Expenses Current Carrying value as of the balance sheet date of obligations incurred through that date and payable for accrued clinical trial expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued clinical trial expenses Accrued Professional Fees, Current Accrued professional fees Employee-related Liabilities, Current Accrued compensation and benefits Accrued Royalties, Current Accrued royalties Other Accrued Liabilities, Current Accrued other Accrued Royalties Accrued royalties Common Stock Common Stock, par value $0.0001 per share Common Stock [Member] SBA EIDL (including accrued interest) (Note 8) Company’s debt Represents the amount of SBA EIDL including accrued interest payable. SBAEIDLincluding Accrued Interest Current Beginning balance Ending balance Derivative Liabilities (Note 9) Total derivative liabilities Derivative Liability, Current SBA EIDL (including accrued interest) (Note 8) Represents the amount of SBA EIDL including accrued interest long-term debt payable. SBAEIDLincluding Accrued Interest Non Current Commitments and Contingencies (Note 12) Commitments and Contingencies Series A Preferred Stock, $0.0001 par value, 1,000,000 shares authorized; 76,480 and 76,480 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively (Note 7) Preferred Stock, Value, Issued Common Stock, $0.0001 par value, 150,000,000 shares authorized; 2,659,288 and 1,163,142 shares issued and outstanding as of Jun 30, 2026 and Dec 31, 2025, respectively (Note 7) Common Stock, Value, Issued Provision for Income Taxes (Note 10) Income Tax Expense (Benefit) Provision for income taxes SHAREHOLDERS' EQUITY SHAREHOLDERS' EQUITY Equity [Text Block] ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts Payable and Accrued Liabilities Disclosure [Text Block] ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts Payable and Accrued Expenses (Note 6) Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities, Current Total Accounts payable and accrued expenses Contractual Obligation, to be Paid, Year One Company’s debt Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Issuance of common stock for granted restricted stock units (in Shares) Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Issuance of common stock for granted restricted stock units